Menu

School of Nursing Newsroom

Ahn awarded $2.4 million grant to study nonpharmacological knee pain treatment

Dr. Brian Ahn
Dr. Brian Ahn
Brian Ahn and lab coordinator Lindsey Park collect brain imaging data from patient Deborah Brown as part of an earlier tDCS study.
Brian Ahn and lab coordinator Lindsey Park collect brain imaging data from patient Deborah Brown as part of an earlier tDCS study. (Photo courtesy UTHealth Public Affairs.)

HOUSTON (May 12, 2020) - A five-year grant awarded last month to Associate Professor Hyochol “Brian” Ahn, PhD, ANP-BC, will fund his continued research into nonpharmacological treatments for knee pain that focus on altering how the brain perceives pain. 

Ahn is the Cizik School of Nursing’s Theodore J. and Mary E. Trumble Professor in Aging Research. He received a $2.4 million grant from the National Institutes of Health (NIH) through the National Institute of Nursing Research (NINR) in April to study transcranial direct current stimulation (tDCS) combined with mindfulness-based meditation for home-based self-management of pain related to knee osteoarthritis in older adults. 

“I am so proud of the determination of our research faculty and honored to be part of our research department, where the depth and breadth of our research is significantly expanding,” said Constance Johnson, PhD, associate dean and Maria C. and Christopher J. Pappas Family Distinguished Chair of the Cizik School of Nursing’s research department. “Dr. Ahn has certainly made a large contribution to our growth. His current funding will not only help to advance his field of research, but will also help to improve our NIH ranking and thus our overall school ranking.” 

An adult nurse practitioner, Ahn holds multiple degrees in electrical engineering and nursing. He has applied this varied background to establish a program of clinical and translational research that enhances health and independence in older adults using innovative technologies to optimize pain management. 

The new grant builds on Ahn’s previous research and complements an on-going, three-year NIH/NINR-funded R15 study involving self-administered tDCS. On the strength of Ahn’s research and his proposal, the grant awarded in April was approved on its first submission. 

“Finding a nonpharmacological approach is very important,” Ahn said. “Most of the pharmacological approaches produce side effects, addiction or tolerance problems.” 

The success of massage, acupressure and other nonpharmacological treatments focused on the knee itself have been limited. Instead, much of Ahn’s research looks at the effectiveness of stimulating the brain to reduce the perception of pain. 

The severity of osteoarthritic conditions revealed by X-rays often doesn’t match the degree of pain reported by the patient, Ahn said. “Pain is their own perception,” he noted. “There is increased pain-related activation with osteoarthritis.” 

The tDCS treatment can be considered “brain massage therapy,” Dr. Ahn said. The new grant will study applying technology to provide this treatment at home to older patients who may have mobility issues, and it will look at whether tDCS can improve the effectiveness of concurrent mindfulness meditation in easing pain. 

Ahn will work with Kenneth Mathis, MD, an orthopedic surgeon with UT Physicians and an associate professor at McGovern Medical School at UTHealth, to make the study available to patients in his practice. 

Kenneth Mathis

Dr. Kenneth Mathis

“This important study may provide further evidence that tDCS could eventually bring a drug-free pain relief modality to millions of patients worldwide and further reduce the need for opiate pain medication," Dr. Mathis said.

Two hundred patients will be recruited for the double-blind, randomized, sham-controlled study. Participants will be divided into four groups that will receive tDCS alone, mindfulness meditation alone, the two approaches combined, or a “sham” treatment that mimics but does not apply the combined treatment. 

Patients will take home a small piece of headgear and a cellphone-sized device that connects to their computer as well a guided medication CD. A secure video conferencing platform will be used to conduct 20-minute, at-home sessions five days a week, and patients will come into the office once a week for brain imaging to gauge the treatment’s effectiveness, Ahn explained. 

Ahn and his research team published a study in 2018 demonstrating the effectiveness of tDCS provided in the office setting. 

“I believe we can do it in a virtual manner,” Ahn said. “A user-friendly home-based therapy would save time, effort and money.”

by Sherri Deatherage Green

Read more about Ahn awarded $2.4 million grant to study nonpharmacological knee pain treatment


In this story


Hyochol "Brian" Ahn, PhD, RN, MSN, MS-ECE, MS-CTS, ANP-BC

site var = son